2022-04-12T13:04:14-05:00 2021-06-30 363321958 Desmond & Ahern Ltd 10827 S Western Avenue Chicago IL 60643 990 2020-07-01 366009467 Orthopaedic Research and Education Foundation ORTH 8476989980 9400 W Higgins Road No 215 Rosemont IL 60018 Joshua Jacobs MD Treasurer 8476989980 2022-04-12 1 Joshua Jacobs MD 999009999 Jason L Gierhahn P02385275 7737794720 2022-04-12 2 AAL1 IAL1 2020 2022-09-23 18:48:47Z OREF Richard Kyle MD 9400 W Higgins Road No 215 Rosemont IL 60018 6977447 0 X www.oref.org X 1955 IL Improving lives by supporting excellence in orthopaedic research. 21 21 12 200 0 0 3932349 2959720 0 0 504463 895658 0 0 4436812 3855378 2898801 1144615 0 0 1675389 1712035 0 0 678162 850754 651305 5424944 3507955 -988132 347423 23173135 25903586 4510722 4144211 18662413 21759375 The Orthopaedic Research and Education Foundation (OREF) mission is improving lives by supporting excellence in orthopaedic research. OREF's vision is that it will be the leader in supporting orthopaedic research to improve function, eliminate pain and restore mobility. 0 0 1884570 1144615 Grant program: The purpose of OREF is to support research into the causes and treatment of musculoskeletal diseases and injuries. OREF's niche is supporting surgeon-researchers and PHD-researchers in basic science/translation, clinical, and health services research. OREF's education program offers new orthopaedic medical researchers the opportunity to develop their research interests and skills. Through educational programming, OREF supports emerging talent to help them successfully pursue research careers. 1884570 1 1 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 14 0 1 12 1 0 0 0 0 0 0 0 0 0 0 0 0 X 21 21 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AK AL AR AZ CA CT DC DE FL GA IL IN KS KY LA MA MD ME MI MS MN MO MT NC ND NE NH NM NY OH OK OR PA RI SC SD TN UT VA WA WI WV WY X X Rhonda Dirr 8476445574 9400 W Higgins Road Rosemont IL 60018 Richard F Kyle MD President 5.00 X X 0 0 0 Joshua J Jacobs MD Treasurer 5.00 X X 0 0 0 Jeffrey S Abrams MD Chair, Corporate Advisory 5.00 X 0 0 0 Francis Y Lee MD PhD Chair Grants 5.00 X 0 0 0 Richard F Santore MD Chair-Individual Developme 5.00 X 0 0 0 Mary Lloyd Ireland MD Trustee 5.00 X 0 0 0 Michael M Chau MD PhD Trustee 5.00 X 0 0 0 Thomas P Sculco MD President-elect 5.00 X X 0 0 0 Christopher R Adams MD Trustee 5.00 X 0 0 0 Jeremie M Axe MD Trustee 5.00 X 0 0 0 B Sonny Bal MD JD MBA PhD Trustee 5.00 X 0 0 0 Nicholas M Bernthal MD Trustee 5.00 X 0 0 0 Eric V Dremel Trustee 5.00 X 0 0 0 Michael P Bolognesi MD Trustee 5.00 X 0 0 0 Karen L Hackett Trustee 5.00 X 0 0 0 James R Ficke MD Trustee 5.00 X 0 0 0 David C Templeman MD Trustee 5.00 X 0 0 0 Stuart Weinstein MD Trustee 5.00 X 0 0 0 Andrew N Pollak MD Trustee 5.00 X 0 0 0 Annuunziato Amendola MD Trustee 5.00 X 0 0 0 Daniel J Berry MD Trustee 5.00 X 0 0 0 Lee Grossman CEO 40.00 X 251372 0 38011 Deborah Cummins VP of Research and Grants 40.00 X 120458 0 27854 Edward Hoover Senior VP of Development 40.00 X 161273 0 10829 Karen Pubentz Sr. Director of Communicat 40.00 X 127470 0 19809 John Johnson Campaigns Director 40.00 X 101604 0 4262 762177 0 100765 5 0 1 0 0 231330 2728390 2959720 389234 389234 3628493 3122069 506424 506424 506424 3855378 0 0 895658 1144615 1144615 309394 34033 176355 99006 1064406 352195 410278 301933 68242 23314 25691 19237 175144 55399 69643 50102 94849 27269 39998 27582 56632 16282 23882 16468 4411 1268 1860 1283 19215 19215 34832 17416 17416 113923 67239 3744 42940 67324 14401 37379 15544 107346 30862 45268 31216 127510 29925 58579 39006 209 209 1025 525 500 16433 4724 6931 4778 87955 64192 14064 9699 Bad debt 9496 9496 Dues and subscriptions 4994 1436 2106 1452 3507955 1884570 945223 678162 271 271 3573378 2762829 1880985 1256334 40764 69083 245168 206932 54669 38236 12482662 16546668 5140406 5230165 23173135 25903586 175458 169669 3767264 3299365 568000 675177 4510722 4144211 X 662656 112873 17999757 21646502 18662413 21759375 23173135 25903586 X 347423 2733888 15651 X X 0 1 X 1 0 X 4715824 5448193 3198011 3932349 2959720 20254097 4715824 5448193 3198011 3932349 2959720 20254097 2438467 17815630 431365 506240 441988 467531 389234 2236358 22490455 0.79210 0.79590 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 X 10199908 7026 3592759 558254 13241439 7961755 13785 -82175 19900 7873465 8311807 35531 733712 1119295 7961755 8014335 46789 250683 8311807 7306263 10723 778493 81144 8014335 0 0 50447 37854 12593 130696 109062 21634 64025 60016 4009 38236 Charitable Remainder Trust Receivable 3366166 Cash Surrender Value of Life Insurance 1849915 Other receivables 14084 5230165 Due to Orthopaedic Partners 675177 675177 X 6661451 2733888 72185 2806073 3855378 0 3855378 3451421 -56534 -56534 3507955 0 3507955 Part IV, Line 2b: On behalf of other orthopaedic organizations, the Foundation accepts contributions for which it performs recordkeeping and provides grants requested by those organizations. Part X, Line 2: FIN 48 Note from Audited Financial Statements: The Foundation, an Illinois nonprofit corporation, is exempt from income taxes under Section 501(c)(3) of the Internal Revenue Code and applicable state law, except for taxes pertaining to unrelated business income, if any. The Foundation's annual information and income tax returns filed with the federal and state governments are subject to examination generally for three years after they are filed. The Foundation has adopted the requirements for accounting for uncertain tax positions and management has determined that the Foundation was not required to record a liability related to uncertain tax positions as of June 30, 2021. Part XI, Line 2d - Other Adjustments: Change in cash surrender value of life insurance policies 91,148. Change in charitable remainder trust receivable -18,963. Part XII, Line 2d - Other Adjustments: Orthopaedic partner endowment distribution -56,534. 1 The Regents of the University of California San Francisco (Contracts & Gra UCSF Office of Sponsored Research 490 Illinois Street 4th Floor San Francisco CA 94143 946036493 223340 Pilot RCT to Evaluate Local Gentamicin for Tibia Fractures in Tanzania Saint Louis University 221 North Grand Boulevard St Louis MO 63103 430654872 145803 Local Bisphosphonate Effect on Recurrence Rate in Giant Cell Tumor of Bone Washington University in StLouis Campus Box 1054 One Brookings Drive St Louis MO 631304862 430653611 20000 Mediators of the OA Cascade in the Pre-Arthritic Hip Washington University in StLouis Campus Box 1054 One Brookings Drive St Louis MO 631304862 430653611 20000 Understanding Barriers to Delivery of Care for Brachial Plexus Injury The Regents of the University of California San Francisco (Contracts & Gra UCSF Office of Sponsored Research 490 Illinois Street 4th Floor San Francisco CA 94143 946036493 55000 The Use of Venlafaxine in Reducing Surgical Pain in Total Knee Arthroplasty Columbia University Medical Center Sponsored Projects Administration Columbia University 630 West 168th New York NY 10032 135598093 20000 Inflammation in Rotator Cuff Tear and Repair The Board of Trustees of the Leland Stanford Junior University Research Management Group 455 Broadway Discovery Hall 2nd Floor M Redwood City CA 940633126 941156365 20000 RENEWAL: Developing and Testing a Tool for Preference Elicitation in CTS Orthopaedic Research and Education Foundation 9400 West Higgins Road Suite 215 Rosemont IL 600184975 366009467 20000 Clinical Research Award - Epidemiology, Mechanisms, and Prevention of Sports Injury The Regents of the University of California Los Angeles University of California Los Angeles Office of Contract and Gran Los Angeles CA 900951406 956006143 20000 Targeting Molecules to the Enthesis via Novel Bisphosphonate Chaperones The Hospital for Special Surgery 535 East 70th Street New York NY 10021 131624135 20000 Epidural Steroids to Reduce Opioid Consumption following Laminectomy Dartmouth-Hitchcock Clinic One Medical Center Drive Lebanon NH 03756 222519596 19906 Characterizing the Microbiome of Native, Aseptic Bilateral Knee Joints The Hospital for Special Surgery 535 East 70th Street New York NY 10021 131624135 20000 Effect of Surface Finish on Head-Neck Corrosion in Total Hip Arthroplasty The Regents of the University of California Los Angeles University of California Los Angeles Office of Contract and Gran Los Angeles CA 900951406 956006143 20000 Cost-effective analysis of below-knee prostheses for Tanzanian amputees University of Rochester 518 Hylan Bldg Box 270140 Rochester NY 146270140 160743209 250000 Identification of FGF18 gene regulatory network in hip OA using scRNA-Seq The Regents of the University of California Los Angeles University of California Los Angeles Office of Contract and Gran Los Angeles CA 900951406 956006143 50000 BMP Receptor Ligand Traps as a Therapy for Post-traumatic Osteoarthritis The Hospital for Special Surgery 535 East 70th Street New York NY 10021 131624135 50000 PRP treatment of the ACL-injured knee to decrease the risk of PTOA Part I, Line 2: The Research Grants Committee is responsible for allocating research funding to advance research in the specialty of orthopaedics and is empowered to establish criteria for the allocation and distribution of philanthropic funds to advance research in the specialty of orthopaedics, implement and conduct independent peer review process to select research funding recipients, prepare and distribute necessary promotional information and application forms for research grants and awards and to accept and allocate or decline to allocate, at its sole and absolute discretion, grants and awards for research. One-year grant recipients receive 50% of the funds to start, then 40% after a six-month financial report is received. A final scientific and lay report within 60 days after the grant ends along with a final financial report is required. Once OREF has the final reports the remaining 10% of the funds are released. One-time award/educational grant/lectureship grants receive full payment after they are approved. Documentation is in the file for lectureships, educational programs and awards. Two or three-year grants are paid and spread over the term of the grant. 10% is withheld until all of the reports are received. Multi-year grant recipients submit annual scientific reports which are then reviewed by the original peer review committee member. X X 0 0 0 0 0 0 0 0 0 Lee Grossman CEO 251372 0 0 0 0 0 10343 0 27668 0 289383 0 0 0 Edward Hoover Senior VP of Development 161273 0 0 0 0 0 6412 0 4417 0 172102 0 0 0 Form 990, Part VI, Section B, line 11b The Finance Committee reviewed and approved the Form 990. It was provided to the Board of Trustees, who had an opportunity to review the return prior to filing. Form 990, Part VI, Section B, line 12c All Trustees annual conflict of interest statements are on file with the OREF CEO. The CEO reviews meeting agendas prior to the meeting and notifies leadership of any issues that need to be addressed before the discussions take place. Any individual who gives notice of a potential conflict is to abstain from participation in discussions related to that item. Form 990, Part VI, Section B, line 15 The Foundation has a formal process to determine the compensation of its CEO. The process includes the following: 1) Review and approval by the Board of Trustees or Compensation Committee; 2) Use of comparable compensation data; 3) Contemporaneous documentation and record keepping. Form 990, Part VI, Section C, line 19 The Foundation made its governing documents, conflict of interest policy, and financial statements available to the public upon request for the period of disclosure set forth in IRC Section 6104(d). Form 990, Part XI, line 9: Orthopaedic partner endowment distribution -56,534. Change in cash surrender value of life insurance policies 91,148. Change in charitable remainder trust receivable -18,963. Form 990, Part XII, line 2c: The process has not changed from the prior year. Charitable Remainder Trusts Charitable trusts IL T 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0